Dietary Nut and Legume Intake and Risk of Crohn's Disease and Ulcerative Colitis

被引:0
作者
Lopes, Emily W. [1 ,2 ]
Yu, Zeling [1 ]
Walsh, Shawna E. [3 ]
Casey, Kevin [2 ]
Ananthakrishnan, Ashwin N. [1 ,2 ]
Richter, James M. [1 ]
Burke, Kristin E. [1 ,2 ]
Chan, Andrew T. [1 ,2 ,4 ]
Khalili, Hamed [1 ,2 ,4 ,5 ]
机构
[1] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA USA
[3] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[5] Broad Inst & Harvard, Cambridge, MA USA
基金
美国国家卫生研究院;
关键词
Crohn's disease; ulcerative colitis; inflammatory bowel disease; nutrition; body mass index; MEDITERRANEAN DIET; GUT MICROBIOME; HEART-DISEASE; CONSUMPTION; ASSOCIATIONS; VALIDITY; ADULTS;
D O I
10.1093/ibd/izaf032
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: We investigated the relationship between nut and legume intake and risk of Crohn's disease (CD) and ulcerative colitis (UC). Methods: We conducted a prospective cohort study of 223 283 adults from the Nurses' Health Study (NHS), NHSII, and Health Professionals Follow-Up Study (1986-2017), excluding those with inflammatory bowel disease (IBD) at baseline. Food frequency questionnaires were used to calculate nut and legume intake. Inflammatory bowel disease was self-reported on questionnaires and confirmed via blinded record review. Using Cox proportional hazards models, we calculated adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for CD and UC according to categories of nut and legume intake. Results: In over 5 460 315 person-years of follow-up (CD = 371, UC = 481), neither nut nor legume intake was associated with CD or UC risk. Compared to those who never consumed nuts, those who consumed nuts >= 2 times/week had an aHR = 0.96 (95% CI, 0.63-1.47; P-trend = 0.57) for CD and 1.30 (95% CI, 0.92-1.84; P-trend = 0.36) for UC. Compared to those who consumed legumes 0-3 times/month, those who consumed legumes >= 4 times/week had an aHR of 1.26 (95% CI, 0.78-2.04; P-trend = 0.59) for CD and 0.72 (95% CI, 0.44-1.18; P-trend = 0.20) for UC. Baseline BMI modified the relationship between nut intake and CD risk (P-int = 0.03). In those with BMI >= 25, the aHR for CD was 0.14 (95% CI, 0.03-0.56; P = .006) per additional serving/day of nuts compared with 0.88 (95% CI, 0.45-1.74; P = .72) for those with BMI <25. Conclusions: Nut and legume intake were not associated with CD or UC risk. However, higher nut intake decreased CD risk in overweight or obese individuals. Thus, personalized-risk stratification, rather than generalized dietary recommendations, may be important for IBD prevention strategies. Lay Summary Here, we show that overall nut and legume intake was not associated with risk for development of IBD; however, higher nut intake decreased Crohn's disease risk in those with elevated body mass index.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Dietary inflammatory potential, genetic predisposition, and incidence of Crohn’s disease and ulcerative colitis
    Ji-Mei Gu
    Miao Zhao
    Jie Zhu
    Hao-Wei Tao
    Xiao-Ping Shao
    Li-Qiang Qin
    Yang-Yang Ge
    Guo-Chong Chen
    Nutrition & Metabolism, 22 (1)
  • [22] Ulcerative colitis or Crohn's disease? Pitfalls and problems
    Feakins, Roger M.
    HISTOPATHOLOGY, 2014, 64 (03) : 317 - 335
  • [23] Prevalence of ulcerative colitis and Crohn's disease in Japan
    Asakura, Keiko
    Nishiwaki, Yuji
    Inoue, Nagamu
    Hibi, Toshifumi
    Watanabe, Mamoru
    Takebayashi, Toru
    JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) : 659 - 665
  • [24] Crohn's disease and ulcerative colitis, major similarities
    Dalibon, Pierre
    ACTUALITES PHARMACEUTIQUES, 2015, 54 (545): : 20 - 24
  • [25] Psoriasis associated with ulcerative colitis and Crohn's disease
    Cohen, A. D.
    Dreiher, J.
    Birkenfeld, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (05) : 561 - 565
  • [26] Wernicke's encephalopathy in Crohn's disease and ulcerative colitis
    Oudman, Erik
    Wijnia, Jan W.
    Oey, Misha J.
    van Dam, Mirjam
    Postma, Albert
    NUTRITION, 2021, 86
  • [27] The role of filgotinib in ulcerative colitis and Crohn's disease
    Fanizza, Jacopo
    D'Amico, Ferdinando
    Lauri, Gaetano
    Martinez-Dominguez, Samuel J.
    Allocca, Mariangela
    Furfaro, Federica
    Zilli, Alessandra
    Fiorino, Gionata
    Parigi, Tommaso Lorenzo
    Radice, Simona
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    IMMUNOTHERAPY, 2024, 16 (02) : 59 - 74
  • [28] Hormone Therapy Increases Risk of Ulcerative Colitis but not Crohn's Disease
    Khalili, Hamed
    Higuchi, Leslie M.
    Ananthakrishnan, Ashwin N.
    Manson, Joann E.
    Feskanich, Diane
    Richter, James M.
    Fuchs, Charles S.
    Chan, Andrew T.
    GASTROENTEROLOGY, 2012, 143 (05) : 1199 - 1206
  • [29] Management of ulcerative colitis and Crohn's disease
    Baert, F
    Vermeire, S
    Noman, M
    Van Assche, G
    Haens, GD
    Rutgeerts, P
    ACTA CLINICA BELGICA, 2004, 59 (05) : 304 - 314
  • [30] Pathogenesis of Crohn's disease and ulcerative colitis
    Autschbach, F
    Otto, HF
    CHIRURGISCHE GASTROENTEROLOGIE, 1998, 14 (02): : 98 - 103